Martinez, Ana <br/><br/>
First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.  [electronic resource] 

 -  Journal of medicinal chemistry  Mar 2002 
 - 1292-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm011020u  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Alzheimer Disease--drug therapy<br/>Amino Acid Sequence<br/>Animals<br/>Binding, Competitive<br/>Calcium-Calmodulin-Dependent Protein Kinases--antagonists & inhibitors<br/>Enzyme Inhibitors--chemical synthesis<br/>Glycogen Synthase Kinase 3<br/>Glycogen Synthase Kinases<br/>Humans<br/>Molecular Sequence Data<br/>Rabbits<br/>Rats<br/>Structure-Activity Relationship<br/>Thiadiazoles--chemical synthesis